Serine racemase Activators
The chemical class of Serine racemase activators presents a rich array of compounds that intricately modulate the activity of Serine racemase, a pivotal enzyme involved in the process of serine racemization. This diverse group of activators can be broadly categorized into two main classes based on their mechanisms of action, offering researchers a multifaceted toolkit for studying and manipulating Serine racemase activity within cellular contexts. The first category comprises direct agonists of the NMDA receptor, including D-cycloserine, NMDA, and D-Serine. These compounds act as initiators of calcium influx, positively influencing Serine racemase activity through the activation of the N-methyl-D-aspartate (NMDA) receptor. The resulting cascade of events, triggered by calcium influx, plays a crucial role in enhancing the enzymatic activity of Serine racemase. This direct modulation represents a cornerstone in understanding the intricate regulatory mechanisms governing serine racemization processes.
In contrast, the second category includes compounds such as A769662 and Aniracetam, which indirectly activate Serine racemase by targeting distinct cellular pathways. A769662 operates through the AMP-activated protein kinase (AMPK) pathway, while Aniracetam influences the AMPA receptor pathway, both leading to increased intracellular calcium levels. This indirect activation underscores the interconnected nature of cellular signaling pathways and their impact on Serine racemase activity. Moreover, inhibitors targeting negative regulators, such as Rapamycin and KN-62, which act on the mTOR and CaMKII pathways, respectively, contribute to enhanced Serine racemase activation. By negating the inhibitory effects imposed by these pathways, these compounds unravel the intricate interplay between regulatory mechanisms and Serine racemase. This nuanced understanding of activators and inhibitors provides researchers with a powerful toolkit to decipher the complex network of biochemical and cellular pathways influenced by Serine racemase, thereby advancing our comprehension of serine racemization processes and their broader implications in cellular physiology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calcium | 7440-70-2 | sc-252536 | 5 g | $209.00 | ||
Elevated intracellular calcium levels can stimulate serine racemase activity, as calcium serves as a key cofactor for its enzymatic function. | ||||||
D-Cycloserine | 68-41-7 | sc-221470 sc-221470A sc-221470B sc-221470C | 200 mg 1 g 5 g 25 g | $28.00 $77.00 $142.00 $530.00 | 4 | |
An antibiotic and partial agonist of the NMDA receptor. D-cycloserine directly activates the NMDA receptor, leading to increased intracellular calcium levels. The elevated calcium levels positively modulate the activity of Serine racemase, promoting its activation and subsequent serine racemization. | ||||||
N-Methyl-D-Aspartic acid (NMDA) | 6384-92-5 | sc-200458 sc-200458A | 50 mg 250 mg | $109.00 $369.00 | 2 | |
A synthetic glutamate analog and a potent agonist of the NMDA receptor. NMDA directly activates the NMDA receptor, inducing calcium influx. The elevated intracellular calcium levels positively influence Serine racemase activity, supporting its role in serine racemization. | ||||||
D-Serine | 312-84-5 | sc-391671 sc-391671A sc-391671B | 5 g 25 g 100 g | $43.00 $128.00 $204.00 | ||
An endogenous ligand for the glycine site of the NMDA receptor. D-Serine acts as a direct activator of the NMDA receptor, leading to increased calcium influx. The enhanced calcium levels positively modulate Serine racemase activity, promoting serine racemization within the cellular context. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A potent AMP-activated protein kinase (AMPK) activator. A769662 directly activates AMPK, leading to the phosphorylation and activation of Serine racemase. The activation occurs through the AMPK-mediated signaling pathway, positively regulating Serine racemase activity. | ||||||
Aniracetam | 72432-10-1 | sc-203514 sc-203514A | 50 mg 250 mg | $115.00 $456.00 | ||
A nootropic compound and positive modulator of AMPA receptors. Aniracetam indirectly activates Serine racemase by enhancing AMPA receptor activity, leading to increased intracellular calcium levels. The elevated calcium levels positively influence Serine racemase, supporting its activation and serine racemization. | ||||||
D-α-Cyclohexylglycine | 14328-52-0 | sc-255050 | 5 g | $198.00 | ||
A selective antagonist of the glycine site on the NMDA receptor. D-cyclohexylglycine indirectly activates Serine racemase by blocking the inhibitory effects of the NMDA receptor. The removal of inhibition leads to increased Serine racemase activity, promoting serine racemization within the cellular context. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor. Rapamycin indirectly activates Serine racemase by inhibiting the mTOR pathway. Serine racemase activity is negatively regulated by mTOR, and inhibition of this pathway by Rapamycin leads to increased Serine racemase activation, promoting serine racemization within the cellular context. | ||||||
KN-62 | 127191-97-3 | sc-3560 | 1 mg | $136.00 | 20 | |
A selective inhibitor of CaMKII. KN-62 indirectly activates Serine racemase by blocking the inhibitory effects of CaMKII. Serine racemase activity is negatively regulated by CaMKII, and inhibition of this kinase by KN-62 leads to enhanced Serine racemase activation, supporting serine racemization within the cellular context. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
A major polyphenol in green tea. EGCG indirectly activates Serine racemase by inhibiting the mTOR pathway. Serine racemase activity is negatively regulated by mTOR, and EGCG's inhibition of this pathway leads to increased Serine racemase activation, promoting serine racemization within the cellular context. | ||||||